COMMUNIQUÉS West-GlobeNewswire

BELLUS Santé annonce les résultats positifs principaux de l’étude de phase 1 pour le BLU-5937, son médicament candidat phare pour le traitement de la toux chronique
19/11/2018
BELLUS Santé annonce les résultats positifs principaux de l’étude de phase 1 pour le BLU-5937, son médicament candidat phare pour le traitement de la toux chronique - Aucune perte du goût aux doses thérapeutiques [...]
DeLibra Wesley Named to the SIA List, Global Power 150 – Women in Staffing 2018
19/11/2018
The list recognizes female leadership and contributions to the global staffing industry DALLAS, Nov. 19, 2018 (GLOBE NEWSWIRE) -- The Delta Companies (TDC), a leading staffing firm for healthcare professionals [...]
GEn1E Lifesciences Adds to Development Pipeline with Exclusive Option to License University of Maryland, Baltimore’s MUC1-Ecto-Domain Anti-Bacterial Agent
19/11/2018
Provides GEn1E the potential to enter clinic with a therapy for Pseudomonas infections in Cystic Fibrosis patients PALO ALTO, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- GEn1E Lifesciences Inc. (“GEn1E”), a pre-clinical [...]
Sanofi: Disclosure of trading in own shares
19/11/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
19/11/2018
Pièce jointe Reporting FR.pdf
SuperSonic Imagine Spotlights Groundbreaking Aixplorer® MACH 30 Platform at RSNA 2018
19/11/2018
A sleek, intuitive new platform ready for AI, Aixplorer MACH 30 has all the assets to address the United States’ market for today and in the future AIX-EN-PROVENCE, France, Nov. 19, 2018 (GLOBE NEWSWIRE) -- SuperSonic [...]
InMed of Coral Springs Implements eRAD RIS and Speech Recognition
19/11/2018
Customer expands its platform to reap benefits of integration GREENVILLE, S.C., Nov. 19, 2018 (GLOBE NEWSWIRE) -- InMed Diagnostic of Coral Springs, FL, a multi-modality imaging provider in South Florida, has deployed [...]
Ossur Hf :Transactions in relation to share buyback program
19/11/2018
Announcement no. 67/2018 19 November 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Replacement CT Tube Solutions from Richardson Healthcare at RSNA 2018
19/11/2018
Stop by Booth 7330 to see the ALTA750™ CT Tube LAFOX, Ill., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Richardson Healthcare , a Division of Richardson Electronics, Ltd. (NASDAQ: RELL), will be displaying the ALTA750 replacement [...]
UPDATE -- Cellworks to Present 10 Abstracts at 2018 American Society of Hematology Annual Meeting
19/11/2018
ASH Abstracts Reveal How AI-Driven Biosimulation Technology Predicts Drug Response in Individual Cancer Patients with High Accuracy SAN JOSE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in [...]
Cellworks to Present 10 Abstracts at 2019 American Society of Hematology Annual Meeting
19/11/2018
ASH Abstracts Reveal How AI-Driven Biosimulation Technology Predicts Drug Response in Individual Cancer Patients with High Accuracy SAN JOSE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in [...]
ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018
19/11/2018
Amsterdam, The Netherlands - 19 November 2018 Esperite announces that the preparation of its Annual Report 2017 is now under final review by its auditors and should be published before 24 November 2018. About ESPERITE [...]
Galectin Therapeutics to Present at the 2nd Annual Anti-Fibrotic Drug Development Summit
19/11/2018
NORCROSS, Ga., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold H. Shlevin, the Company’s [...]
Corcept Therapeutics Announces First Patient Dosed in Phase 3 Trial of Relacorilant to Treat Patients with Cushing’s Syndrome
19/11/2018
MENLO PARK, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic [...]
Akers Biosciences Exploring Potential Business Combinations in Alternative Sectors Including Cannabis Industry
19/11/2018
THOROFARE, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, is pleased to provide an [...]
Who Will Become the LaCroix of CBD Beverages -- CFN Media
19/11/2018
SEATTLE, Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
TOMI Environmental Solutions, Inc. Reports Record Third Quarter 2018 Financial Results
19/11/2018
BEVERLY HILLS, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, including [...]
Lotus Cannabis LP - Launches Strategic Plan
19/11/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Lotus Ventures Inc. (CSE – J) (“the Company”) held a strategy [...]
Immuron Appoints Gary S. Jacob, Ph.D., Experienced US Based Biotechnology Executive, as CEO
19/11/2018
MELBOURNE, Australia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Immuron Limited, (IMC or the Company), (ASX: IMC; NASDAQ: IMRN), is pleased to announce the appointment of Gary S. Jacob as Chief Executive Officer. Dr Jacob is [...]

Pages